Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists

'antagonist':19,42,65,86 'disord':15,37,60,81 'fill':21,39,44,62 'inject':66,82 'injector':43,61 'name':17,84 'opioid':8,10,13,18,30,32,35,41,53,55,58,64,74,76,79,85 'overdos':9,31,54,75 'pharmaceut':1,16,23,46,67,83 'revers':11,33,56,77 'syring':20,38 'treatment':6,28,51,72 'use':3,14,25,36,48,59,69,80

NALMEFENE HCL

Owners

Goods & Services